ConductScience.org, home

Gene · 29949

IL19: interleukin 19

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. IL19: interleukin 19. Genes, record 29949. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/29949

On this page

Gene

Symbol
IL19
HGNC
Name
interleukin 19
HGNC
NCBI Gene ID
29949
NCBI Gene
HGNC ID
HGNC:5990
HGNC
Ensembl
ENSG00000142224
NCBI Gene
Aliases
IL-10C, IL-19, MDA1, NG.1, ZMDA1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9UHD0Interleukin-191771Ensembl, GeneID, HGNC

Source UniProt

Patents205

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4705273 A22026-03-11292Q9UHD0Espacenet
JP 2026004568 A2026-01-1450205Q9UHD0Espacenet
EP 4650780 A22025-11-192733Q9UHD0Espacenet
US 12473363 B22025-11-18914Q9UHD0Espacenet
US 12459997 B22025-11-041Q9UHD0Espacenet
JP 2025147176 A2025-10-066950Q9UHD0Espacenet
JP 2025147176 A2025-10-066951Q9UHD0Espacenet
JP 2025529142 A2025-09-042082Q9UHD0Espacenet
JP 2025529142 A2025-09-046712Q9UHD0Espacenet
US 12371689 B22025-07-292082Q9UHD0Espacenet

1 to 10 of 205

See all 205 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants978

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleIL19 papersNewest fiscal year
P30CA016672Cancer Center Support Grant72025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success72025
P30AR075043University of Michigan Skin Biology and Diseases Resource-based Center52025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital52025
U01DK062413Determining genomic and host-environment contributions to IBD phenotypes52025
ZIAAI001065India International Center for Excellence in Research52025
ZIAAR041159Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases52025
P30CA016059Massey Cancer Center - Cancer Center Support Grant42025
U01DK062423Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes42025
P30AR075049Northwestern University Skin Biology and Diseases Resource-based Center32025

1 to 10 of 978Source NIH's project files

See all 978 nih grants

Papers1,818

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Investigating the causal impact of gut microbiota on periodontitis based on Mendelian randomization, bulk transcriptomics, and single-cell transcriptomics.Front Cell Dev Biol202642688170PubTator, text miningPubMed
IL-19+ monocytes suppress neuroinflammation and promote neurological recovery in young individuals with traumatic brain injury.Cell Rep202642570240PubTator, text miningPubMed
IL-19 limits macrophage-driven inflammation in acetaminophen-induced liver injury.J Hepatol202642497925PubTator, text miningPubMed
The proteomic and metabolomic signature of inherited chromosomally integrated HHV-6 and its role in all-cause dementia and mortality risk: The UK Biobank study.Alzheimers Dement (N Y)202642483205PubTator, text miningPubMed
Integration of periodontal pathogens and inflammatory mediators in saliva as biomarkers for periodontitis.Front Cell Infect Microbiol202642482995PubTator, text miningPubMed
IL-19 Modulates Antiviral Immunity and Inflammation via IL-20RB/STAT3/TRIM22 Signaling Pathway.J Med Virol202642473417PubTator, text miningPubMed
Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study.Am J Phys Med Rehabil202642464048PubTator, text miningPubMed
Dynamics of the Interleukin-10 Family of Cytokines in Chronic Otitis Media Patients upon 1,8-Cineol Treatment.In Vivo202642379782PubTator, text miningPubMed
Transcriptional immune programs underlying inadequate response to tumor necrosis factor inhibitors in ankylosing spondylitis.Clin Immunol202642289261PubTator, text miningPubMed
Anti-Inflammatory Interleukins in the Pathogenesis of Atherosclerosis.Int J Mol Sci202642278553PubTator, text miningPubMed

1 to 10 of 1,818

See all 1,818 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/29949

GET https://conductscience.org/api/genes/v1/29949/patents?page=2